Monday, January 11th 2021 at 12:00pm UTC —New 103,720 ft2 Facility to Serve as Headquarters and House 150 Employees in…
Monday, January 11th 2021 at 12:58pm UTC AXA1665 Phase 2 trial initiation planned for Q2 AXA1125 Phase 2b trial initiation…
Wednesday, January 13th 2021 at 2:00pm UTC TORONTO–(BUSINESS WIRE)– Throughout this pandemic we’ve all had to find new ways of…
Monday, January 11th 2021 at 1:00pm UTC HAMILTON, Ontario–(BUSINESS WIRE)– With a flurry of new COVID-19 outbreaks in Hamilton hospitals,…
Wednesday, January 20th 2021 at 12:00pm UTC LEXINGTON, Mass.–(BUSINESS WIRE)– Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company…
Monday, January 11th 2021 at 11:30am UTC DURHAM, N.C.–(BUSINESS WIRE)– Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused…
Wednesday, January 20th 2021 at 12:05pm UTC Phase 1 study includes late-line patients and patients with AR-v7 splice variants for…
Wednesday, January 20th 2021 at 4:00pm UTC *NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE…
Wednesday, January 20th 2021 at 5:42pm UTC –(BUSINESS WIRE)– Miller Thomson LLP requests that their press release NewsItemId: 20210120005542…
Monday, January 11th 2021 at 9:01pm UTC MENLO PARK, Calif.–(BUSINESS WIRE)– Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics…